Why is Zydus Lifesci. falling/rising?

As of 18-Sep, Zydus Lifesciences Ltd's stock price is currently at 1,047.90, reflecting an increase of 14.45, or 1.4%. The stock has shown a positive trend today, outperforming its sector by 0.35% and reversing a three-day decline. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish momentum. Additionally, the stock has seen a rise in investor participation, with a delivery volume increase of 35.33% compared to the 5-day average. Over the past week, the stock has gained 0.37%, while it has performed better over the last month with a 6.03% increase, although it has declined by 3.06% over the past year. The company's strong fundamentals, including low debt levels, consistent profit growth, and high return on equity, contribute positively to its recent price movement.
In the broader market context, Zydus Lifesciences Ltd's short-term performance has lagged behind the benchmark Sensex, which has risen by 1.80% over the past week. However, the company's long-term growth prospects remain robust, with a significant 190.60% increase over the past three years, compared to the Sensex's 41.08% rise in the same period. The company's solid financial health, evidenced by a low debt-to-equity ratio and consistent positive results over the last nine quarters, positions it favorably in the market. Despite the recent underperformance relative to the benchmark, the overall positive indicators suggest that the stock's upward movement may continue, supported by strong fundamentals and investor confidence.